UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial

Annals of oncology, 2003-01, Vol.14 (1), p.97-104

2003

Volltextzugriff (PDF)

Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial

Annals of oncology, 2004-03, Vol.15 (3), p.478-483

2004

Volltextzugriff (PDF)

Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma

British journal of cancer, 2003-04, Vol.88 (8), p.1180-1184

2003

Volltextzugriff (PDF)

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer

Annals of oncology, 2001-02, Vol.12 (2), p.183-186

2001

Volltextzugriff (PDF)

Side effects during chemotherapy predict tumour response in advanced colorectal cancer

British journal of cancer, 2005-10, Vol.93 (7), p.744-748

2005

Volltextzugriff (PDF)

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

The New England journal of medicine, 2009-02, Vol.360 (7), p.679-691

2009

Volltextzugriff (PDF)

Randomized Multicenter Phase II Trial of Oxaliplatin Plus Irinotecan Versus Raltitrexed as First-Line Treatment in Advanced Colorectal Cancer

Journal of clinical oncology, 2002-01, Vol.20 (1), p.165-172

Scheithauer, W.

2002

Volltextzugriff (PDF)

Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer

Journal of clinical oncology, 1994-05, Vol.12 (5), p.970-974

1994

Volltextzugriff (PDF)

Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and or erythropoietin in patients with advanced gastric cancer

British journal of cancer, 2002-06, Vol.86 (12), p.1858-1863

2002

Volltextzugriff (PDF)

Treatment of Advanced Breast Cancer with Vinorelbine and Docetaxel With or Without Human Granulocyte Colony-Stimulating Factor

Journal of clinical oncology, 2001-02, Vol.19 (3), p.621-627

2001

Volltextzugriff (PDF)

Long-term follow-up of surgically treated gallbladder cancer patients

European journal of surgical oncology, 2002-12, Vol.28 (8), p.857-863

2002

Volltextzugriff (PDF)

Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy

Annals of oncology, 2001-05, Vol.12 (5), p.709-714

2001

Volltextzugriff (PDF)

MRP and MDR1 gene expression in primary breast carcinomas

Clinical cancer research, 1996-07, Vol.2 (7), p.1231-1237

1996

Volltextzugriff (PDF)

Randomized Multicenter Phase II Trial of Two Different Schedules of Capecitabine Plus Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

Journal of clinical oncology, 2003-04, Vol.21 (7), p.1307-1312

2003

Volltextzugriff (PDF)

Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin

British journal of cancer, 2000-01, Vol.82 (1), p.98-103

2000

Volltextzugriff (PDF)

Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma

British Journal of Cancer, 1999-08, Vol.80 (11), p.1797-1802

1999

Volltextzugriff (PDF)

Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III study

Journal of clinical oncology, 1997-03, Vol.15 (3), p.908-914

1997

Volltextzugriff (PDF)

Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy

Annals of oncology, 2001-09, Vol.12 (9), p.1269-1272

2001

Volltextzugriff (PDF)

Overexpression of Hypoxia-inducible Factor 1α Is Associated with an Unfavorable Prognosis in Lymph Node-positive Breast Cancer

Clinical cancer research, 2002-06, Vol.8 (6), p.1831-1837

2002

Volltextzugriff (PDF)

Expression of the multidrug resistance-associated protein ( ) gene in colorectal carcinomas

British journal of cancer, 1997-01, Vol.75 (2), p.208-212

1997

Volltextzugriff (PDF)

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer

BMJ. British medical journal (International ed.), 1993-03, Vol.306 (6880), p.752

International edition, 1993

Volltextzugriff (PDF)

Second-line treatment of advanced gastric cancer with oxaliplatin plus raltitrexed

Oncology research and treatment, 2003-06, Vol.26 (3), p.255-258

2003

Volltextzugriff (PDF)

Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based Therapy

Clinical cancer research, 2008-03, Vol.14 (6), p.1767-1774

2008

Volltextzugriff (PDF)

Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancer

British journal of cancer, 1998-09, Vol.78 (6), p.760-764

1998

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(94)

Publikationsform

Artikel
(142)

Sprache

Englisch
(97)
Deutsch
(45)

Erscheinungsjahr

n.n

Thema

Humans
(96)
Female
(73)
Life Sciences & Biomedicine
(69)
Science & Technology
(69)
Middle Aged
(67)
Aged
(64)
Adult
(61)
Oncology
(58)
Male
(54)
Biological And Medical Sciences
(49)
Medical Sciences
(49)
Pharmacology. Drug Treatments
(37)
Antineoplastic Agents
(36)
Chemotherapy
(34)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(30)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(21)
Follow-Up Studies
(21)
Prognosis
(18)
Survival Rate
(18)
Treatment Outcome
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial

Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial

Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer

Side effects during chemotherapy predict tumour response in advanced colorectal cancer

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

Randomized Multicenter Phase II Trial of Oxaliplatin Plus Irinotecan Versus Raltitrexed as First-Line Treatment in Advanced Colorectal Cancer

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer

Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and or erythropoietin in patients with advanced gastric cancer

Treatment of Advanced Breast Cancer with Vinorelbine and Docetaxel With or Without Human Granulocyte Colony-Stimulating Factor

Long-term follow-up of surgically treated gallbladder cancer patients

Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy

MRP and MDR1 gene expression in primary breast carcinomas

Randomized Multicenter Phase II Trial of Two Different Schedules of Capecitabine Plus Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin

Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma

Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III study

Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy

Overexpression of Hypoxia-inducible Factor 1α Is Associated with an Unfavorable Prognosis in Lymph Node-positive Breast Cancer

Expression of the multidrug resistance-associated protein ( ) gene in colorectal carcinomas

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer

Second-line treatment of advanced gastric cancer with oxaliplatin plus raltitrexed

Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based Therapy

Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancer

Suchergebnisse filtern